139 related articles for article (PubMed ID: 26277483)
1. Tumor infiltration pattern into the surrounding tissue has prognostic significance in advanced gastric cancer.
Saito H; Miyatani K; Takaya S; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ikeguchi M
Virchows Arch; 2015 Nov; 467(5):519-23. PubMed ID: 26277483
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tumour infiltration growth pattern in patients with advanced gastric cancer.
Zhao B; Zhang J; Mei D; Huang X; Zou S; Luo R; Xu H; Huang B
J Clin Pathol; 2019 Feb; 72(2):165-171. PubMed ID: 30467239
[TBL] [Abstract][Full Text] [Related]
3. Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer.
Kanda M; Mizuno A; Fujii T; Shimoyama Y; Yamada S; Tanaka C; Kobayashi D; Koike M; Iwata N; Niwa Y; Hayashi M; Takami H; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Jun; 23(6):1934-40. PubMed ID: 26847679
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
[TBL] [Abstract][Full Text] [Related]
5. Tumor infiltrative growth pattern correlates with the immune microenvironment and is an independent factor for lymph node metastasis and prognosis in stage T1 esophageal squamous cell carcinoma.
Zhao Y; Xu E; Yang X; Zhang Y; Chen H; Wang Y; Jin M
Virchows Arch; 2020 Sep; 477(3):401-408. PubMed ID: 32232560
[TBL] [Abstract][Full Text] [Related]
6. Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series.
Baiocchi GL; Molfino S; Baronchelli C; Giacopuzzi S; Marrelli D; Morgagni P; Bencivenga M; Saragoni L; Vindigni C; Portolani N; Botticini M; De Manzoni G
World J Gastroenterol; 2017 Dec; 23(45):8000-8007. PubMed ID: 29259375
[TBL] [Abstract][Full Text] [Related]
7. Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients.
Masuda R; Kijima H; Imamura N; Aruga N; Nakamura Y; Masuda D; Takeichi H; Kato N; Nakagawa T; Tanaka M; Inokuchi S; Iwazaki M
Mol Med Rep; 2012 Nov; 6(5):937-43. PubMed ID: 22940760
[TBL] [Abstract][Full Text] [Related]
8. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosis.
Chou HH; Kuo CJ; Hsu JT; Chen TH; Lin CJ; Tseng JH; Yeh TS; Hwang TL; Jan YY
Am J Surg; 2013 Jun; 205(6):623-30. PubMed ID: 23036602
[TBL] [Abstract][Full Text] [Related]
10. Analysis of immune status in gastric adenocarcinoma with different infiltrating patterns and origin sites.
Zhang N; Wang D; Hu X; Zhang G; Li Z; Zhao Y; Liu Z; Wang Y
Front Immunol; 2022; 13():978715. PubMed ID: 36081505
[TBL] [Abstract][Full Text] [Related]
11. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
[TBL] [Abstract][Full Text] [Related]
14. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
15. Impact of Subclassification of Serosal Invasion on the Survival of Patients With T4a Gastric Cancer.
Nakamura K; Tajima K; Kanamori K; Yatabe K; Ogimi M; Higuchi T; Yamamoto M; Hara H; Kazuno A; Nabeshima K; Nomura E; Koyanagi K
In Vivo; 2022; 36(4):1923-1929. PubMed ID: 35738632
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the number of examined lymph nodes in node-negative gastric adenocarcinoma.
Hsu JT; Lin CJ; Sung CM; Yeh HC; Chen TH; Chen TC; Chiang KC; Yeh TS; Hwang TL; Jan YY
Eur J Surg Oncol; 2013 Nov; 39(11):1287-93. PubMed ID: 23973513
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features and outcome of surgical treatment of 149 patients with early (pT1) gastric cancer.
Skoropad V; Berdov B; Zagrebin V
Onkologie; 2005 May; 28(5):247-52. PubMed ID: 15867480
[TBL] [Abstract][Full Text] [Related]
18. Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach.
Saito H; Fukumoto Y; Osaki T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
World J Surg; 2006 Oct; 30(10):1864-9. PubMed ID: 16983479
[TBL] [Abstract][Full Text] [Related]
19. Impact of tumor infiltration pattern into the surrounding tissue on prognosis of the subserosal gastric cancer (pT2b).
Song KY; Hur H; Jung CK; Jung ES; Kim SN; Jeon HM; Park CH
Eur J Surg Oncol; 2010 Jun; 36(6):563-7. PubMed ID: 20462730
[TBL] [Abstract][Full Text] [Related]
20. Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi-institutional dataset.
Nakagawa N; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
Cancer Med; 2018 Dec; 7(12):6020-6029. PubMed ID: 30411544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
